EX-10.139 6 d325247dex10139.htm DEVELOPMENT, LICENSE AND SUPPLY AGREEMENT Ex 10.139License and Supply Agreement • May 5th, 2020
Contract Type FiledMay 5th, 2020The confidential portions of this exhibit have been filed separately with the Securities and Exchange Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities and Exchange Act of 1934, as amended. REDACTED PORTIONS OF THIS EXHIBIT ARE MARKED BY AN ***.
The confidential portions of this exhibit have been filed separately with the Securities and Exchange Commission pursuant to a confidential treatment request in accordance with Rule 24b-2 of the Securities and Exchange Act of 1934, as amended....License and Supply Agreement • May 1st, 2012 • Endo Pharmaceuticals Holdings Inc • Pharmaceutical preparations
Contract Type FiledMay 1st, 2012 Company IndustryWHEREAS, ENDO intends to develop and/or have developed pharmaceutical preparations containing Oxymorphone as the active ingredient and incorporating GRÜNENTHAL’s tamper resistant formulation technology.